SELECTED PUBLICATIONS:
-
Chaney S.G.and Vaisman A. Specificity of Platinum DNA Adduct Repair. Journal
of Inorganic Biochemistry, 77:71-81.
-
Chaney S.G.,Vaisman A., DNA adduct tolerance and bypass: Platinum-Based
Drugs in Cancer Therapy, Chapter 9, Humana Press, in press.
-
Vaisman A, Lim SE, Patrick SM, Copeland WC, Hinkle
DC, Turchi JJ, Chaney SG: (1999). The
Effect of DNA Polymerases and HMG1 on the Carrier Ligand Specificity for
Translesion Synthesis Past Pt-DNA Adducts, Biochemistry, 38:11026-11039.
-
Reardon JT, Vaisman A, Chaney SG, and Sancar A (1999).
Efficient
Nucleotide Excision Repair of Cisplatin, Oxaliplatin and JM216 Platinum
Intrastrand DNA Diadducts Cancer Res., 59:3968-3971.
-
Vaisman, A., Varchenko, M., Umar, A., Kunkel, T.A., Risinger, J.I., Barrett,
J.C., Hamilton, T.C., & Chaney, S.G. (1998). The
role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance:
correlation with replicative bypass of platinum- DNA adducts. Cancer
Res., 58, 3579-3585.
-
Vaisman, A., Varchenko, M., Said, I., & Chaney, S.G. (1997). Cell
cycle changes associated with formation of Pt-DNA adducts in human ovarian
carcinoma cells with different cisplatin sensitivity. Cytometry,
27,
54-64.
-
Delmastro, D.A., Li, J., Vaisman, A., Solle, M., & Chaney, S.G. (1997).
DNA
damage inducible-gene expression following platinum treatment in human
ovarian carcinoma cell lines. Cancer Chemother.Pharmacol., 39,
245-253.
-
Vaisman, A., Keeney, S., Nichols, A.F., Linn, S., & Chaney, S.G. (1996).
Cisplatin-induced
alterations in the expression of the mRNAs for UV- damage recognition protein.
Oncol.Res.,
8,
7-12.
-
Shea T., Graham M., Bernard S., Steagall A., Wiley
J., Serody J., Brecher M., Bentley S. Johnston C.,
Vaisman A., Chaney S.G., Letrent S., Brouer K. A
clinical and pharmacokinetic study of high-dose carboplatin, paclitaxel,
granulocyte colony-stimulating factor, and peripheral blood stem cells
in patients with unresectable or metastatic cancer. Seminars
in Oncology. 1995, 22, 80-5.
-
Vaisman, A. & Chaney, S.G. (1995). Induction
of UV-damage recognition protein by cisplatin treatment. Biochemistry,
34,
105-114.
-
Thompson, D.C., Vaisman, A., Sakata, M.K., Wyrick, S.D., Holbrook, D.J.,
& Chaney, S.G. (1995). Organ-specific
biotransformation of ormaplatin in the Fischer 344 rat. Cancer Chemother.Pharmacol.,
36,
439-447.
|
